Hughes, M;
Denton, CP;
Khanna, D;
(2021)
Rituximab for the treatment of systemic sclerosis-interstitial lung disease.
Rheumatology
, 60
(2)
pp. 489-491.
10.1093/rheumatology/keaa675.
Preview |
Text
RTX SSc-ILD Rheum -for UCL upload 2020.pdf - Accepted Version Download (163kB) | Preview |
Abstract
This editorial refers to ‘Rituximab in the treatment of systemic sclerosis--related interstitial lung disease: a systematic review and meta-analysis’, by Rudra Goswami et al., on pages 557–567.
| Type: | Article |
|---|---|
| Title: | Rituximab for the treatment of systemic sclerosis-interstitial lung disease |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/rheumatology/keaa675 |
| Publisher version: | https://doi.org/10.1093/rheumatology/keaa675 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10117108 |
Downloads since deposit
128Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
